ICAM1 and gastric cancer: Despite the cross-reactivity of CAR T cells against ICAM-1, we have not observed any significant off-tumor expansion of CAR T cells in our previous xenograft models including systemic ATC 8505C and gastric cancer Hs 746T36,42,49.